Welcome to our dedicated page for Cigna Group news (Ticker: CI), a resource for investors and traders seeking the latest updates and insights on Cigna Group stock.
The Cigna Group (NYSE: CI) is a global health company whose news flow reflects its broad role across health insurance, pharmacy benefit services, specialty pharmacy, care services, and health research. Company announcements frequently emphasize its focus on health, vitality, and community, and they highlight activities under both the Cigna Healthcare and Evernorth Health Services brands.
Investors and observers following The Cigna Group’s news can expect regular earnings releases and outlook updates, including quarterly financial results, segment performance for Evernorth Health Services and Cigna Healthcare, and commentary on adjusted income from operations. These releases often discuss drivers such as pharmacy benefit services growth, specialty pharmacy volume, medical care ratios, and the impact of portfolio changes like the divestiture of certain Medicare businesses.
News from The Cigna Group also covers capital and governance developments, such as dividend declarations, debt offerings and use of proceeds, and changes to Board committee structures and membership. SEC-related communications and press releases may describe new senior notes, committee realignments, and Board retirements or appointments.
Another recurring theme in the company’s news is health services and innovation. Through Evernorth Health Services, The Cigna Group has announced initiatives such as a rebate-free pharmacy benefit model designed to make negotiated discounts available upfront and to support local pharmacies, as well as workplace-based care collaborations like the Hankook Tire Clinic Powered by Evernorth. These stories illustrate how the company applies its pharmacy, care, and benefit capabilities in real-world settings.
The Cigna Group also issues research and community-focused news, including its Vitality in America reports on purpose and health, and sponsorships like the Achilles Freedom Team for wounded veterans and adaptive athletes. For anyone tracking CI, the news stream offers insight into financial performance, strategic direction, health services innovation, and community engagement. Bookmarking this page provides a centralized view of these ongoing developments.
Evernorth, a health services subsidiary of Cigna, and Kaiser Permanente announce a five-year collaboration aimed at enhancing access to affordable, high-quality healthcare for Kaiser members. Effective immediately, the partnership allows Kaiser members traveling outside service areas to utilize Cigna's extensive PPO provider network, improving access to urgent and emergency care. Moreover, Evernorth's Accredo specialty pharmacy will become Kaiser’s preferred external pharmacy, promising savings and enhanced services for specialty drug needs.
The Cigna Corporation (NYSE: CI) will announce its first quarter 2022 financial results on May 6, 2022, at 6:30 a.m. ET. A conference call will follow at 8:30 a.m. ET to discuss these results, with call-in numbers provided for domestic and international participants. A replay of the call will be available starting at 12:30 p.m. ET the same day until 11:59 p.m. ET on May 20, 2022. The financial details will also be accessible via the Investor Relations section of Cigna's website.
Cigna Corporation (NYSE:CI) will host its Investor Day on June 3, 2022, in New York City. The event will run from 8:30 a.m. ET to 1:30 p.m. ET, featuring in-depth presentations on corporate strategy and financial targets. A live webcast will be available on Cigna's Investor Relations website, with a replay accessible for four weeks post-event. Cigna is dedicated to enhancing the health and well-being of individuals through integrated health services.
Cigna Corporation (NYSE: CI) announced a strategic plan for capital deployment aimed at enhancing shareholder value, projecting over $12 billion in deployable capital for 2022. This includes $5.4 billion from the sale of its international insurance businesses. The Board approved a $6 billion increase in share repurchase authorization, bringing the total to $10 billion. Cigna plans to allocate more than $7 billion for share repurchases this year, reinforcing confidence in its growth prospects while also approving $450 million for Cigna Ventures to support innovation.
Cigna Corporation (NYSE:CI) announced that CFO Brian Evanko will present at the Barclays Global Healthcare Conference on March 16, 2022, in Miami, FL. The presentation is set to begin at approximately 1:35 p.m. ET. A live webcast will be available on Cigna's investor relations page. Cigna aims to enhance health services globally, maintaining over 185 million customer relationships across more than 30 countries.
Cigna Corporation (NYSE: CI) announced the retirement of John Murabito, long-serving Chief Human Resources Officer and Chief Administrative Officer, effective April 1. Cynthia Ryan, who has been with Cigna for 23 years, has been appointed as the new CHRO. Murabito's leadership was pivotal in developing a strong HR team to support Cigna's 70,000 employees globally. Ryan, a seasoned HR professional, aims to strengthen employee engagement and talent management. This leadership transition is seen as a crucial step in adapting to a changing talent landscape, enhancing Cigna's strategic growth initiatives.
Evernorth, the health services division of Cigna (NYSE: CI), has partnered with Monument to enhance access to alcohol use disorder (AUD) treatment through Monument's virtual platform. This initiative benefits millions of customers, making therapy, medications, and peer support available to Evernorth and Cigna health plan clients in 20 states. Evernorth aims to address the rising alcohol use, reported to have increased for nearly 60% of individuals during the pandemic. Both companies emphasize their commitment to improving health outcomes through innovative, affordable treatment options.
Cigna Corporation (NYSE:CI) announced that Eric Palmer, CEO of Evernorth, will present at the Cowen 42nd Annual Health Care Conference on March 7, 2022. The presentation, starting at 10:30 a.m. ET, will be accessible via a live webcast on Cigna's investor relations page. The company, dedicated to improving health and well-being globally, offers a wide range of health services and maintains customer relationships in over 30 countries.
Accredo, a specialty pharmacy under Evernorth, Cigna's health services arm, has received URAC's Rare Disease Pharmacy Center of Excellence designation. This accreditation highlights Accredo's dedication to quality health services and improved outcomes for patients with rare diseases. With an estimated 25 to 30 million individuals affected by rare diseases in the U.S., Accredo's specialized resources include a team of about 500 pharmacists and 600 nurses, catering to 23 different rare diseases. URAC accreditation indicates excellence in patient care and safety.
Cigna Corporation reported total revenues of $174.1 billion in 2021, with a net income of $5.4 billion, or $15.73 per share. Adjusted income from operations was $7.0 billion, equating to $20.47 per share. For 2022, Cigna expects adjusted income from operations of at least $6.95 billion and a quarterly dividend increase of 12%, raising it to $1.12 per share. The company continues to experience strong customer growth, with total medical customers rising to 17.1 million.